Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Acarix USA Inc.

OK, United States

CMS manufacturer 100001021883

Open in the dashboard

General payments

$234,383

214 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Acarix USA Inc. reported paying $234,383 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $1,218 19
2024 General $215,303 83
2023 General $2,408 95
2022 General $15,454 17

Breakdown

Top recipients General payments · program year 2025
  1. Jered Cook Cardiovascular Disease · Oklahoma City, OK $191 2 payments
  2. Joshua Lampert Clinical Cardiac Electrophysiology · New York, NY $142 2 payments
  3. Tony Das Interventional Cardiology · Dallas, TX $135 1 payment
  4. Dhanunjaya Lakkireddy Clinical Cardiac Electrophysiology · Kansas City, KS $116 1 payment
  5. Ashok Kondur Interventional Cardiology · Dearborn, MI $116 1 payment
  6. Gaurav Aggarwala Cardiovascular Disease · Huntsville, TX $115 2 payments
  7. Sang Lee Emergency Medical Services · Bethany, OK $95 1 payment
  8. Asif Ali Cardiovascular Disease · Houston, TX $71 1 payment
  9. George Chrysant Interventional Cardiology · Oklahoma City, OK $54 1 payment
  10. Chad Bonhomme Clinical Cardiac Electrophysiology · Westfield, IN $54 1 payment
Products the payments named General payments · program year 2025
  1. CADScor System Cardiology $1,218 100% · 16 recipients

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $439 36% · 7 practitioners
  2. Interventional Cardiology Internal Medicine $329 27% · 4 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $311 26% · 3 practitioners
  4. Emergency Medical Services Emergency Medicine $95 8% · 1 practitioner
  5. Family Medicine $44 4% · 1 practitioner

Each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Texas $389 32% · 7 recipients
  2. Oklahoma $383 31% · 4 recipients
  3. New York $142 12% · 1 recipient
  4. Michigan $116 10% · 1 recipient
  5. Kansas $116 10% · 1 recipient

The top 5 of 7 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2022–2025
  1. Consulting Fee $227,986 12 payments
  2. Food and Beverage $5,197 201 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,200 1 payment
214 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record